CCI
BIIB icon

Columbus Circle Investors’s Biogen BIIB Stock Holding History

Columbus Circle Investors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-149,379
Closed -$40.8M – 250
2017
Q1 		$40.8M Buy
149,379
+30,667
+26% +$8.67M 0.57% 59
2016
Q4 		$33.7M Buy
+118,712
New +$35.2M 0.44% 69
2016
Q1 		– Sell
-16,692
Closed -$5.11M – 268
2015
Q4 		$5.11M Sell
16,692
-1,601
-9% -$460K 0.04% 225
2015
Q3 		$5.34M Sell
18,293
-455,154
-96% -$150M 0.04% 223
2015
Q2 		$191M Sell
473,447
-134,497
-22% -$54M 1.35% 16
2015
Q1 		$257M Sell
607,944
-52,398
-8% -$20.7M 1.75% 10
2014
Q4 		$224M Sell
660,342
-545,650
-45% -$177M 1.59% 14
2014
Q3 		$399M Sell
1,205,992
-140,868
-10% -$46.4M 2.86% 3
2014
Q2 		$425M Buy
1,346,860
+14,295
+1% +$4.3M 2.9% 2
2014
Q1 		$408M Buy
1,332,565
+148,241
+13% +$47.1M 2.71% 1
2013
Q4 		$331M Sell
1,184,324
-15,095
-1% -$3.9M 2.26% 3
2013
Q3 		$289M Buy
1,199,419
+58,433
+5% +$13.1M 2.05% 3
2013
Q2 		$246M Buy
+1,140,986
New +$244M 1.97% 4

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Columbus Circle Investors's BIIB Position: Q2 2017 in Review

Columbus Circle Investors sold out of Biogen (BIIB) in Q2 2017, closing a stake of 149,379 shares — an estimated $40.8M sold.

Columbus Circle Investors first reported a position in BIIB in Q2 2013 and held it in 13 quarters. The position peaked at $425M in Q2 2014. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Columbus Circle Investors reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 149,379 Biogen shares in Q2 2017, an estimated $40.8M.
  • Columbus Circle Investors first reported a position in Biogen in Q2 2013 and held it in 13 quarters.
  • Columbus Circle Investors's Biogen position peaked at $425M in Q2 2014.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Columbus Circle Investors's 13F filing for Q2 2017, filed 4 Aug 2017.